Sartorius Stedim Biotech (DIMN) Revenue
Sartorius Stedim Biotech Revenue
Sartorius Stedim Biotech had a revenue of 762.10M in the quarter ending Sep 30, 2026, with -0.47%. This bring the company's revenue in the last twelve months to 3.06B, Increased 1.88%. In the fiscal year ending Dec 31, 2025, Sartorius Stedim Biotech had annual revenue of 2.97B with 6.74% growth.
- Revenue (ttm)
- 3.06B
- Revenue Growth
- -1.92%
- P/S Ratio
- 154.25
- Revenue/Employee
- MXN 283,077
- Employees
- 10,483
- Market Cap
- MXN 457.73B
Revenue Chart
Sartorius Stedim Biotech Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.97B | 187.50M | 6.74% |
| Dec 31, 2024 | 2.78B | 4.50M | 0.16% |
| Dec 31, 2023 | 2.78B | -717.20M | -20.53% |
| Dec 31, 2022 | 3.49B | 605.72M | 20.98% |
| Dec 31, 2021 | 2.89B | 976.90M | 51.14% |
| Dec 31, 2020 | 1.91B | 469.51M | 32.59% |
| Dec 31, 2019 | 1.44B | 228.42M | 18.84% |
| Dec 31, 2018 | 1.21B | 131.12M | 12.13% |
| Dec 31, 2017 | 1.08B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| MX:DIMN | 3.06B |